MRSJX
Price
$26.94
Change
-$0.13 (-0.48%)
Updated
Nov 13 closing price
Net Assets
17.81B
VTIAX
Price
$40.28
Change
-$0.40 (-0.98%)
Updated
Nov 13 closing price
Net Assets
554.27B
Interact to see
Advertisement

MRSJX vs VTIAX

Header iconMRSJX vs VTIAX Comparison
Open Charts MRSJX vs VTIAXBanner chart's image
MFS Research International R4
Price$26.94
Change-$0.13 (-0.48%)
VolumeN/A
Net Assets17.81B
Vanguard Total Intl Stock Index Admiral
Price$40.28
Change-$0.40 (-0.98%)
VolumeN/A
Net Assets554.27B
MRSJX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
MRSJX vs. VTIAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSJX is a StrongBuy and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. MRSJX (17.8B). VTIAX pays higher dividends than MRSJX: VTIAX (2.70) vs MRSJX (1.71). MRSJX was incepted earlier than VTIAX: MRSJX (21 years) vs VTIAX (15 years). MRSJX (0.74) is less costly to investors than VTIAX (0.09). MRSJX is a more actively managed with annual turnover of: 17.00 vs. VTIAX (3.00). MRSJX has a lower initial minimum investment than VTIAX: MRSJX (0) vs VTIAX (3000). VTIAX annual gain was more profitable for investors over the last year : 25.12 vs. MRSJX (17.28). VTIAX (39.59) and MRSJX (38.24) have equivalent 5 years return.
MRSJXVTIAXMRSJX / VTIAX
Total Expense Ratio0.730.09811%
Annual Report Gross Expense Ratio0.740.09822%
Fund Existence21 years15 years-
Gain YTD20.68728.91272%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.8B554B3%
Annual Yield % from dividends1.712.7063%
Returns for 1 year17.2825.1269%
Returns for 3 years42.1349.2885%
Returns for 5 years38.2439.5997%
Returns for 10 years104.3479.35131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.280.21
+10.14%
Acrivon Therapeutics
MRNA26.710.30
+1.14%
Moderna
EGHAU10.55N/A
N/A
EGH Acquisition Corp.
RAMP30.46-0.42
-1.36%
LiveRamp Holdings
IMRX6.62-0.12
-1.78%
Immuneering Corp